Header Logo

Steven Gitelis

Concepts (281)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bone Neoplasms
33
2023
121
7.270
Why?
Sarcoma
15
2023
144
2.560
Why?
Bone Substitutes
9
2017
32
2.110
Why?
Soft Tissue Neoplasms
7
2022
55
1.780
Why?
Bone Transplantation
8
2017
221
1.630
Why?
Giant Cell Tumor of Bone
5
2022
15
1.620
Why?
Sarcoma, Ewing
3
2020
8
1.450
Why?
Calcium Sulfate
6
2012
27
1.090
Why?
Musculoskeletal Diseases
2
2015
46
0.930
Why?
Limb Salvage
5
2023
12
0.920
Why?
Humans
61
2023
28413
0.850
Why?
Neoplasm Recurrence, Local
7
2023
206
0.820
Why?
Retrospective Studies
27
2023
3613
0.800
Why?
Leiomyosarcoma
1
2021
21
0.720
Why?
Adult
24
2022
8146
0.720
Why?
Adolescent
16
2021
2318
0.710
Why?
Young Adult
13
2021
2102
0.710
Why?
Osteosarcoma
8
2021
37
0.700
Why?
Calcium Phosphates
2
2012
25
0.690
Why?
Hip Joint
2
2016
549
0.670
Why?
Child
13
2021
1423
0.670
Why?
Fractures, Bone
2
2012
75
0.650
Why?
Bone Cysts
2
2016
2
0.640
Why?
Synovitis, Pigmented Villonodular
2
2016
3
0.640
Why?
Child, Preschool
9
2021
692
0.640
Why?
Tibia
2
2010
258
0.600
Why?
Treatment Outcome
16
2023
3619
0.560
Why?
Male
26
2021
15338
0.550
Why?
Chondromatosis, Synovial
1
2016
4
0.550
Why?
Arthroplasty, Replacement, Knee
5
2022
624
0.540
Why?
Middle Aged
21
2021
9308
0.530
Why?
Bone Diseases
2
2017
26
0.530
Why?
Internal Fixators
1
2016
39
0.530
Why?
Arthrodesis
2
2014
42
0.520
Why?
Foot
1
2016
45
0.520
Why?
Radiotherapy
1
2016
34
0.520
Why?
Foreign Bodies
1
2016
30
0.510
Why?
Lymphoma, Non-Hodgkin
1
2016
37
0.510
Why?
Female
23
2021
15762
0.500
Why?
Acetabulum
3
2016
235
0.500
Why?
Ultrasonography, Interventional
1
2016
75
0.500
Why?
Radius
2
2014
33
0.480
Why?
Tobramycin
2
2005
10
0.450
Why?
Knee Prosthesis
2
2008
223
0.450
Why?
Survival Rate
5
2021
356
0.440
Why?
Biopsy
6
2023
221
0.420
Why?
Arthralgia
2
2011
125
0.410
Why?
Cell Transformation, Neoplastic
2
2010
32
0.400
Why?
Anti-Bacterial Agents
3
2022
374
0.400
Why?
Chondrosarcoma
4
2023
33
0.390
Why?
Combined Modality Therapy
3
2021
306
0.390
Why?
Prognosis
8
2023
826
0.380
Why?
Proto-Oncogene Proteins c-akt
3
2017
51
0.370
Why?
Histiocytosis, Sinus
1
2011
4
0.370
Why?
Talus
1
2011
16
0.370
Why?
Allografts
4
2021
222
0.370
Why?
Edema
1
2011
25
0.370
Why?
Patellar Ligament
1
2010
42
0.350
Why?
Follow-Up Studies
8
2022
1870
0.350
Why?
Humerus
3
2005
120
0.330
Why?
Lung Neoplasms
2
2015
555
0.330
Why?
Prosthesis Failure
4
2022
539
0.320
Why?
Osteomyelitis
3
2005
20
0.320
Why?
Debridement
3
2016
102
0.310
Why?
Femur
4
2022
400
0.310
Why?
Bone Plates
1
2008
51
0.290
Why?
Reoperation
6
2022
917
0.290
Why?
Neoadjuvant Therapy
5
2022
66
0.280
Why?
Cisplatin
3
2017
53
0.270
Why?
Aged
12
2021
9314
0.270
Why?
Osteogenesis
1
2007
114
0.270
Why?
Arthroplasty, Replacement, Hip
3
2022
822
0.250
Why?
Curettage
3
2022
9
0.240
Why?
Orthopedic Procedures
3
2004
312
0.240
Why?
Disease-Free Survival
3
2021
177
0.240
Why?
Drug Resistance, Neoplasm
3
2017
63
0.240
Why?
Aged, 80 and over
6
2021
4880
0.230
Why?
Immunohistochemistry
4
2011
364
0.230
Why?
Transplantation, Homologous
2
2004
286
0.230
Why?
Margins of Excision
2
2022
31
0.230
Why?
Infant
3
2021
591
0.220
Why?
Pelvic Bones
1
2004
18
0.220
Why?
Lymphatic Metastasis
2
2021
91
0.220
Why?
Joint Instability
1
2008
397
0.220
Why?
Knee Joint
2
2008
756
0.210
Why?
Spinal Neoplasms
1
2023
38
0.210
Why?
Embolization, Therapeutic
1
2023
60
0.210
Why?
Kidney Neoplasms
1
2023
80
0.210
Why?
Injections
2
2016
45
0.210
Why?
Plasma Gases
1
2022
2
0.200
Why?
Neutrophils
1
2023
106
0.200
Why?
Prostheses and Implants
2
2015
163
0.200
Why?
Neoplasm Staging
3
2022
372
0.200
Why?
Absorbable Implants
1
2002
27
0.200
Why?
Apoptosis
5
2022
205
0.200
Why?
Tomography, X-Ray Computed
4
2015
770
0.200
Why?
Sarcoma, Synovial
1
2022
11
0.200
Why?
Vancomycin
1
2002
52
0.200
Why?
Bone Cements
3
2022
91
0.190
Why?
Infant, Newborn
2
2021
656
0.190
Why?
Radiography
5
2015
652
0.190
Why?
Lymphatic Vessels
1
2021
9
0.180
Why?
Myxosarcoma
1
2020
3
0.180
Why?
Hemipelvectomy
1
2020
2
0.180
Why?
Fibrosarcoma
1
2020
9
0.180
Why?
Pelvic Neoplasms
1
2020
4
0.180
Why?
Orthopedics
1
2002
113
0.180
Why?
Receptor, IGF Type 1
2
2017
19
0.170
Why?
Prosthesis-Related Infections
1
2022
186
0.170
Why?
Hip Prosthesis
2
2022
552
0.170
Why?
Cell Line, Tumor
7
2017
251
0.160
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2016
8
0.160
Why?
Medically Underserved Area
1
2019
16
0.160
Why?
Dogs
4
2007
192
0.160
Why?
Antineoplastic Agents
3
2017
190
0.160
Why?
Chemoradiotherapy
1
2019
61
0.150
Why?
Medical Oncology
1
2019
43
0.150
Why?
Chemotherapy, Adjuvant
2
2010
81
0.150
Why?
Tumor Suppressor Protein p53
2
2016
82
0.150
Why?
Health Services Accessibility
1
2019
113
0.150
Why?
Osteoarthritis
1
2022
332
0.150
Why?
Healthcare Disparities
1
2019
87
0.150
Why?
Receptors, Somatomedin
1
2017
4
0.140
Why?
Protein Kinase Inhibitors
2
2017
50
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
244
0.140
Why?
Imidazoles
1
2017
55
0.140
Why?
Piperazines
1
2017
80
0.130
Why?
Ceramics
1
2016
22
0.130
Why?
Mechanistic Target of Rapamycin Complex 1
1
2016
10
0.130
Why?
Synovectomy
1
2016
5
0.130
Why?
Chondroma
3
2012
5
0.130
Why?
Biocompatible Materials
1
2016
95
0.130
Why?
Child Development
1
2016
75
0.130
Why?
Femoral Neoplasms
1
2015
4
0.120
Why?
Cohort Studies
1
2021
1935
0.120
Why?
Time Factors
3
2022
1499
0.120
Why?
Prosthesis Implantation
1
2015
31
0.120
Why?
Disease Management
1
2016
114
0.120
Why?
Supination
1
2014
19
0.120
Why?
Prosthesis Design
3
2022
503
0.120
Why?
Radiotherapy Dosage
1
2015
117
0.120
Why?
Ossification, Heterotopic
1
2015
36
0.120
Why?
Lung
1
2015
168
0.120
Why?
Arthroplasty
1
2016
150
0.120
Why?
Hand Strength
1
2014
61
0.120
Why?
Wrist Joint
1
2014
62
0.110
Why?
Cartilage, Articular
2
2016
426
0.110
Why?
Drug Implants
2
2005
10
0.110
Why?
Protein Kinases
1
2014
13
0.110
Why?
Risk Factors
2
2022
2413
0.110
Why?
Telomerase
2
2004
9
0.110
Why?
Spinal Fusion
1
2020
474
0.110
Why?
Receptors, Notch
1
2013
1
0.110
Why?
Magnetic Resonance Imaging
2
2011
1197
0.110
Why?
Gene Expression Regulation, Neoplastic
3
2014
113
0.100
Why?
Wnt Proteins
1
2013
22
0.100
Why?
Recovery of Function
2
2012
300
0.100
Why?
Fibrous Dysplasia of Bone
1
2012
3
0.100
Why?
Bone Matrix
2
2003
30
0.100
Why?
Injections, Intralesional
1
2012
33
0.100
Why?
beta Catenin
1
2013
65
0.100
Why?
Bone Regeneration
2
2003
77
0.100
Why?
Diagnosis, Differential
2
2011
370
0.100
Why?
Fluorodeoxyglucose F18
2
2022
38
0.100
Why?
Positron Emission Tomography Computed Tomography
2
2022
34
0.100
Why?
Animals
5
2007
3808
0.090
Why?
Range of Motion, Articular
1
2014
725
0.090
Why?
Ankle
1
2011
24
0.090
Why?
Thoracoscopy
1
2010
23
0.090
Why?
Ilium
1
2010
29
0.090
Why?
Age Factors
2
2019
796
0.080
Why?
Proportional Hazards Models
2
2021
354
0.080
Why?
Predictive Value of Tests
1
2011
494
0.080
Why?
Chicago
1
2012
912
0.080
Why?
Survival Analysis
1
2008
268
0.070
Why?
Compressive Strength
1
2007
25
0.070
Why?
Elasticity
1
2007
34
0.070
Why?
Illinois
1
2008
247
0.070
Why?
Cell Division
3
2022
83
0.070
Why?
Prospective Studies
2
2023
1801
0.070
Why?
Radiation Tolerance
1
2006
6
0.070
Why?
Muscle Proteins
1
2006
32
0.070
Why?
Glycoproteins
1
2006
47
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2006
25
0.070
Why?
Transcription, Genetic
1
2006
108
0.070
Why?
Proteins
1
2006
66
0.070
Why?
Carrier Proteins
1
2006
103
0.060
Why?
Heterocyclic Compounds, 3-Ring
2
2017
13
0.060
Why?
Phosphorylation
2
2016
150
0.060
Why?
Dose-Response Relationship, Drug
1
2005
350
0.060
Why?
Multivariate Analysis
1
2005
334
0.060
Why?
Neoplasm Invasiveness
2
2021
89
0.060
Why?
Blastomycosis
1
2004
21
0.060
Why?
Lower Extremity
1
2023
40
0.050
Why?
Biopsy, Needle
1
2004
107
0.050
Why?
Surgical Flaps
1
2023
51
0.050
Why?
Lymphocyte Count
1
2023
16
0.050
Why?
Bone Demineralization Technique
1
2003
5
0.050
Why?
Tumor Microenvironment
1
2023
16
0.050
Why?
Blood Loss, Surgical
1
2023
59
0.050
Why?
Mutation
2
2021
349
0.050
Why?
Lymphocytes
1
2023
63
0.050
Why?
Exoribonucleases
1
2002
1
0.050
Why?
Preoperative Care
1
2023
125
0.050
Why?
Genes, Tumor Suppressor
1
2002
10
0.050
Why?
Saccharomyces cerevisiae Proteins
1
2002
12
0.050
Why?
Necrosis
1
2022
26
0.050
Why?
Bone Resorption
1
2003
85
0.050
Why?
Replantation
1
2022
10
0.050
Why?
Drug Delivery Systems
1
2002
31
0.050
Why?
Signal Transduction
2
2016
451
0.050
Why?
Transplantation Immunology
1
2002
3
0.050
Why?
Printing, Three-Dimensional
1
2021
9
0.050
Why?
Tissue and Organ Harvesting
1
2002
20
0.050
Why?
Forecasting
1
2002
102
0.050
Why?
Arthroscopy
1
2011
1088
0.050
Why?
Time-to-Treatment
1
2022
35
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2021
47
0.050
Why?
Radiopharmaceuticals
1
2022
54
0.050
Why?
Positron-Emission Tomography
1
2022
90
0.050
Why?
Risk Assessment
1
2004
673
0.050
Why?
SEER Program
1
2021
41
0.050
Why?
Neoplasm Grading
1
2021
52
0.050
Why?
Cartilage
1
2002
103
0.050
Why?
DNA Damage
2
2014
28
0.040
Why?
Chronic Disease
1
2002
443
0.040
Why?
Tendons
1
2002
225
0.040
Why?
Biomechanical Phenomena
1
2002
676
0.040
Why?
Mesna
1
2019
3
0.040
Why?
Tumor Cells, Cultured
3
2004
120
0.040
Why?
Enzyme Activation
2
2014
121
0.040
Why?
Ifosfamide
1
2019
14
0.040
Why?
Organ Sparing Treatments
1
2019
11
0.040
Why?
Leg
1
2019
53
0.040
Why?
Doxorubicin
1
2019
55
0.040
Why?
Arm
1
2019
84
0.040
Why?
Pyrazines
1
2017
10
0.040
Why?
Drug Synergism
1
2017
41
0.040
Why?
Receptor Cross-Talk
1
2016
6
0.030
Why?
Kaplan-Meier Estimate
1
2015
179
0.030
Why?
Checkpoint Kinase 1
1
2014
5
0.030
Why?
Cell Cycle Checkpoints
1
2014
5
0.030
Why?
RNA Interference
1
2014
36
0.030
Why?
Gene Knockdown Techniques
1
2014
45
0.030
Why?
RNA, Small Interfering
1
2014
79
0.030
Why?
Hedgehog Proteins
1
2013
8
0.030
Why?
Culture Techniques
1
1992
17
0.030
Why?
Extracellular Matrix Proteins
1
1992
47
0.020
Why?
Proteoglycans
1
1992
136
0.020
Why?
Acridine Orange
1
2006
1
0.020
Why?
Radiation-Sensitizing Agents
1
2006
5
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2006
56
0.020
Why?
Gamma Rays
1
2006
17
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2006
67
0.020
Why?
Down-Regulation
1
2006
102
0.020
Why?
Cell Survival
1
2006
119
0.020
Why?
Manubrium
1
2004
2
0.010
Why?
Sternoclavicular Joint
1
2004
6
0.010
Why?
Chondrocytes
1
2004
156
0.010
Why?
Models, Animal
1
2003
120
0.010
Why?
DNA, Complementary
1
2002
24
0.010
Why?
Microscopy, Phase-Contrast
1
2002
5
0.010
Why?
Telomere
1
2002
7
0.010
Why?
DNA Mutational Analysis
1
2002
58
0.010
Why?
Biomarkers, Tumor
1
2004
202
0.010
Why?
Base Sequence
1
2002
102
0.010
Why?
DNA-Binding Proteins
1
2004
276
0.010
Why?
RNA, Messenger
1
2002
304
0.010
Why?
Disease Models, Animal
1
2003
629
0.010
Why?
Sepharose
1
1992
4
0.010
Why?
Hexuronic Acids
1
1992
6
0.010
Why?
Glucuronic Acid
1
1992
6
0.010
Why?
Alginates
1
1992
7
0.010
Why?
Keratan Sulfate
1
1992
15
0.010
Why?
Gels
1
1992
13
0.010
Why?
Lectins, C-Type
1
1992
49
0.010
Why?
Microspheres
1
1992
24
0.010
Why?
Cattle
1
1992
126
0.010
Why?
Aggrecans
1
1992
54
0.010
Why?
Extracellular Matrix
1
1992
51
0.010
Why?
Cells, Cultured
1
1992
539
0.010
Why?
Gitelis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (281)
Explore
_
Co-Authors (28)
Explore
_
Similar People (60)
Explore
_
Physical Neighbors
_